| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |